Entrada Therapeutics, Inc. (TRDA) › RevenueEntrada Therapeutics, Inc. (TRDA) — RevenueAnnual figures by fiscal year, from SEC filings.2023: $129.01M2024: $210.78M2025: $25.42M$25.42M2023Revenue (USD)2025Fiscal YearRevenueChange YoY2025$25.42M-87.9%2024$210.78M+63.4%2023$129.01M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share